levodopa-carbidopa: Clinical Trials

8 trials of levodopa-carbidopa, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 completed, 1 recruiting, 1 unknown. 5 Phase 2, 2 Phase 1, 1 Phase 3, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 25Completed 3, Recruiting 1, Unknown 1
Phase 12Completed 2
Phase 31Completed 1
Phase 41Completed 1

Follow levodopa-carbidopa: new trials by email Literature Review of levodopa-carbidopa trials Research Report on levodopa-carbidopa

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Role of Silymarin in Neuroprotection and Symptom Management in Parkinson's Disease
levodopa-carbidopa, Silymarin - Parkinson Disease
Phase 2RecruitingTanta University502025-05-102025-09-10
Montelukast in Parkinson Disease
levodopa-carbidopa, Montelukast - Parkinson Disease
Phase 2 / Phase 3CompletedMostafa Bahaa602023-11-052026-10-02
Clinical Study to Evaluate the Possible Efficacy of Metformin in Patients With Parkinson's Disease
levodopa-carbidopa, Metformin - Parkinson Disease
Phase 2CompletedTanta University602023-01-062026-03-13
Acute Effects of Pharmacological Neuromodulation on Leg Motor Activity in Patients With SCI Treated With EES
Buspirone, Levodopa-Carbidopa, Buspirone + Levodopa-Carbidopa - Spinal Cord Injuries, Drug Effect
Phase 1CompletedCentre Hospitalier Universitaire Vaudois32020-09-112023-10-05
Studying a Potential Protective Effect of L-Dopa on Retinitis Pigmentosa
levodopa-carbidopa - Retinitis Pigmentosa
Phase 2UnknownBeirut Eye Specialist Hospital502016-06-012016-07-19
A Pharmacokinetic Study of Levodopa and Carbidopa Intestinal Gel in Subjects With Advanced Parkinson's Disease
Levodopa-Carbidopa - Parkinson Disease
Phase 1CompletedAbbVie192010-04-012017-11-21
Efficacy, Safety, and Pharmacokinetics/Pharmacodynamic Study of L-Dopa/Carbidopa To Treat Parkinson's Disease
levodopa-carbidopa - Parkinson's Disease
Phase 2CompletedOsmotica Pharmaceutical US LLC782007-11-012009-01-14
Effect of Levodopa-Carbidopa on Visual Function in Patients With Recent-Onset Nonarteritic Anterior Ischemic Optic Neuropathy
levodopa-carbidopa - Nonarteritic Anterior Ischemic Optic Neuropathy
Phase 4CompletedShahid Beheshti University of Medical Sciences2002-06-012008-10-20

Conditions studied

Parkinson Disease (5)  ·  Optic Neuropathy, Ischemic (1)  ·  Retinitis Pigmentosa (1)  ·  Spinal Cord Injuries (1)

Sponsors

Tanta University (2)  ·  AbbVie (1)  ·  Beirut Eye Specialist Hospital (1)  ·  Centre Hospitalier Universitaire Vaudois (1)  ·  Mostafa Bahaa (1)  ·  Osmotica Pharmaceutical US LLC (1)  ·  Shahid Beheshti University of Medical Sciences (1)

Countries

Egypt (3)  ·  Argentina (1)  ·  Iran (1)  ·  Lebanon (1)  ·  Switzerland (1)

Top investigators

Elias F. Jarade, MD (1)  ·  Gustavo Fischbein, M.D. (1)  ·  Janet Benesh (1)  ·  Jocelyne Bloch, Pr MD (1)  ·  Mohammad Pakravan, MD (1)

Results publications

PMID 23229334, PMID 40385486

NIH funding

2009 (1), 2019 (1)